KYMR

Kymera Therapeutics Inc (KYMR) receives a Buy rating from Guggenheim
Samantha Gray
Kymera Therapeutics Inc’s filing revealed that its Chief Executive Officer Mainolfi Nello unloaded Company’s shares for reported $1.83 million on ...

Kymera Therapeutics Inc [KYMR] Stock sold by Insider Gollob Jared for $3.66 million
Roman Campbell
Kymera Therapeutics Inc’s recent filing unveils that its Chief Medical Officer Gollob Jared unloaded Company’s shares for reported $3.66 million ...





